Brazil vs Developing regions: Proportion of the target population who received the final dose
Brazil
79.0%
in 2024
Developing regions
26.0%
in 2024
Brazil rank
24th
Developing regions rank
24th
Proportion of the target population who received the final dose over time
- Brazil
- Developing regions
How they compare
Brazil currently reports 79.0% against 26.0% in Developing regions, a difference of 53.0%.
That makes Brazil's figure about 3.0 times Developing regions's.
Across all 11 years both countries report, Brazil has been ahead every year.
Brazil ranks 24th and Developing regions ranks 24th of 108 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Developing regions | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 68.7% | 7.8% | 60.8% | Brazil |
| 2020s | 73.2% | 14.0% | 59.2% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Brazil or Developing regions?
- Brazil, at 79.0% against 26.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Brazil and Developing regions?
- 53.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Developing regions?
- 11 years are reported by both, from 2014 to 2024.
- How do Brazil and Developing regions rank globally for proportion of the target population who received the final dose of?
- Brazil ranks 24th and Developing regions ranks 24th of 108 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.